Gland Pharma appoints Satnam Singh Loomba as COO, Senior Management Personnel

Written by Ruchika Sharma Published On 2024-04-29T15:55:34+05:30 | Updated On 29 April 2024 3:55 PM IST

Gland Pharma appoints Satnam Singh Loomba as COO, Senior Management Personnel

Telangana: Gland Pharma has appointed Satnam Singh Loomba as Chief Operating Officer (COO); a Senior Management Personnel of the Company, effective May 01, 2024.

"We would like to inform you that upon the recommendation of the Nomination and Remuneration Committee, the Board of Directors of Gland Pharma Limited at its Meeting held today, i.e., Monday, April 29, 2024 has inter-alia considered and approved the appointment of Mr. Satnam Singh Loomba as Chief Operating Officer (COO) and Senior Management Personnel of the Company with effect from May 01, 2024," the Company stated in a BSE filing.

Satnam Singh Loomba is a senior pharmaceutical and management professional with an extensive background in multi-cultural, global environments for pharmaceutical Operations & Business and proficient in several multifunctional departments.

He has over 30 years of experience in API Operations & Development, Global Supply Planning & Operations in Manufacturing, Formulations, Global Material Sourcing, Corporate Strategic Business Planning, and Global Supply Chain for Global Markets. He has experience in managing operations in Formulations in Pharmaceuticals, Narcotics, Cosmetics, Food and Alternate medicine like Sterile Injectables, Infusions, Aerosol based Inhalers, Sprays, Lyophilized products, Insulin, Lozenges, etc. He has been instrumental in attaining accreditations from USFDA, MHRA, EDQM Cofepris, TGA, MCC, Health Canada, ANVISA, PMDA, KFDA.

Before joining Gland, Satnam was associated with Shalina Labs, Harman Finochem, Aurobindo Pharma, Sun Pharmaceuticals and Ranabaxy Laboratories.

Loomba has done his Master of Business Administration from University Business School, Chandigarh. He is also a graduate in Chemical Engineering from Andhra University, Visakhapatnam.

Read also: Gland Pharma bags USFDA nod for Cetrorelix Acetate for Injection

Gland Pharma was established in 1978 in Hyderabad and has grown over the years from a contract manufacturer of small-volume liquid parenteral products to become one of the largest injectable-focused companies, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India, and other markets. It operates primarily under a business-to-business (B2B) model and has an excellent track record in developing, manufacturing, and marketing sterile injectables. It has a wide range of injectables, including vials, ampoules, pre-filled syringes, lyophilized vials, dry powders, infusions, oncology, and ophthalmic solutions.

gland pharmagland pharma newsSatnam Singh Loombaappointment

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751